EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Multi-target Therapeutic Strategy of Traditional Korean Medicine for Excitation/Inhibition Imbalance in Autism Spectrum Disorder-Related Aggression: A Narrative Review of Neuropharmacological Mechanisms

Jin-Chae Park

Journal of Korean Medicine · 01.06.2026 · 47 (2) · 40-62

DOI: 10.13048/jkm.26019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Korean Medicine, online erschienen am 01.06.2026. Verfasst von Jin-Chae Park. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to systematically organize the neuropharmacological evidence for traditional Korean medicine (TKM) prescriptions corresponding to four pathological pathways constituting excitation/inhibition (E/I) imbalance underlying aggression in autism spectrum disorder (ASD).

Methods

A narrative review was conducted from January 2024 to May 2025 across PubMed, Google Scholar, CNKI, and OASIS. Of 412 initially identified articles, 79 were selected for final analysis and classified into four pathways: glutamate excess, GABA deficiency, HPA axis hyperactivation, and sleep disturbance.

Results

Baekho-tang demonstrated anti-inflammatory effects via nanoaggregate-mediated delivery of antipyretic components. Catalpol from Banggi-jihwang-tang showed GABAA receptor binding affinity (Ki ≈ 28.56 nM) with anticonvulsant effects in seizure models, although direct validation in developmental cortex or ASD models has not been reported. Saikosaponin A from Sayeok-san suppressed CRH expression and serum corticosterone in CUMS depression models, while paeoniflorin restored HPA axis negative feedback through glucocorticoid receptor nuclear translocation. Rhynchophylline from Uncaria rhynchophylla demonstrated the broadest multi-target profile, including non-competitive NMDA receptor antagonism (IC₅₀ 43.2 μM (RHY)), serotonin receptor modulation, and dopamine D2 receptor regulation.

Conclusions

TKM prescriptions showed potential alignment with the multi-target therapy paradigm for ASD aggression-related E/I imbalance, with rhynchophylline identified as the most promising candidate. Current evidence is primarily based on preclinical studies of individual components, and whole-formula validation and clinical trials remain critical future priorities.

Zitieren

APA

Park, J. (2026). Multi-target Therapeutic Strategy of Traditional Korean Medicine for Excitation/Inhibition Imbalance in Autism Spectrum Disorder-Related Aggression: A Narrative Review of Neuropharmacological Mechanisms. Journal of Korean Medicine, 47(2), 40-62. https://doi.org/10.13048/jkm.26019

Vancouver

Park J. Multi-target Therapeutic Strategy of Traditional Korean Medicine for Excitation/Inhibition Imbalance in Autism Spectrum Disorder-Related Aggression: A Narrative Review of Neuropharmacological Mechanisms. Journal of Korean Medicine. 2026;47(2):40-62. doi:10.13048/jkm.26019

BibTeX
@article{Park2026,
  author = {Park, Jin-Chae},
  title = {Multi-target Therapeutic Strategy of Traditional Korean Medicine for Excitation/Inhibition Imbalance in Autism Spectrum Disorder-Related Aggression: A Narrative Review of Neuropharmacological Mechanisms},
  journal = {Journal of Korean Medicine},
  year = {2026},
  volume = {47},
  number = {2},
  pages = {40--62},
  doi = {10.13048/jkm.26019}
}
Kostenlos starten →